Dr. Roberto Gabach: “If it is difficult you plan, if it is impossible you try”
Dr. Gabach, our director & manager of New Projects, analyzes the present and gives us a preview of the future of Amarin and the transdermal market. [...]
Shaping the future of pharma
Email: info@amarintech.com.ar
Dr. Gabach, our director & manager of New Projects, analyzes the present and gives us a preview of the future of Amarin and the transdermal market. [...]
The abuse and misuse of antibiotics in animals and humans are contributing to the increased threat posed by antimicrobial resistance. [...]
In transdermal pharmaceutical development, the initial instinct of many business development managers is to default to the largest available CDMO, the assumption being that scale correlates with capability, and that a recognized name reduces risk. [...]
Cleaning validation in transdermal patch manufacturing is a critical GMP requirement that goes beyond routine equipment cleaning. It is the documented, systematic demonstration that an approved cleaning procedure consistently removes active pharmaceutical ingredient (API) residues — and any other contaminants — to levels that cannot compromise the safety, identity, strength, [...]
Contamination of drugs raises concern because of the risks that constant exposure to drugs in the environment and in humans can bring. [...]
A review of the evolution of the transdermal market in the voice of Dr. Francisco Stefano, our director. Challenges of science and passion as protagonists. [...]
In recent years, laboratories have been investigating new alternatives to eliminate or avoid animal testing of cosmetic and medical products. [...]
Correct adhesion of a transdermal patch throughout its entire wear period is not an aesthetic property — it is a drug delivery important condition. A patch that partially lifts off from the skin delivers less drug than labeled, with unpredictable pharmacokinetic consequences [...] [...]
Although the analytical procedure transfer of transdermal pharmaceutical products follows the same general guidelines as other dosage forms, .. [...]
Transdermal patch production is a continuous process that demands precision at every stage and accumulated knowledge of the variables involved. It is not a process mastered quickly. Three articulated stages — mixing, coating/drying/laminating, and die-cutting/packaging — define the final outcome: a transdermal drug delivery system that is safe, effective, and [...]